Botulinum toxin treatment of paraspinal muscles for improving abnormal posture in Parkinson’s disease

Basal Ganglia ◽  
2018 ◽  
Vol 12 ◽  
pp. 1-3 ◽  
Author(s):  
Hideyuki Matsumoto ◽  
Tsugumi Akahori ◽  
Keiko Hatano ◽  
Hideji Hashida
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Botulinum Toxin ◽  
Paraspinal Muscles ◽  
Abnormal Posture ◽  
Botulinum Toxin Treatment

scholarly journals Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment

2005 ◽  
Vol 22 (10) ◽  
pp. 997-1003 ◽  
Author(s):  
F. CADEDDU ◽  
A. R. BENTIVOGLIO ◽  
F. BRANDARA ◽  
G. MARNIGA ◽  
G. BRISINDA ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Botulinum Toxin ◽  
Botulinum Toxin Treatment

scholarly journals Outcome on Balance and Gait Following Botulinum Toxin Treatment for Striatal Foot in Parkinson's Disease

2016 ◽  
Vol 4 (3) ◽  
pp. 309-315 ◽  
Author(s):  
Beata Lindholm ◽  
Anders Beckman ◽  
Wojciech Duzynski ◽  
Eva Ekvall Hansson
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Botulinum Toxin ◽  
Botulinum Toxin Treatment

Effects of Onabotulinum Toxin A on Gait in Parkinson’s Disease Patients with Foot Dystonia

2021 ◽  
pp. 1-6
Author(s):  
Pei Huang ◽  
Yuan-Yuan Li ◽  
Jung E. Park ◽  
Ping Huang ◽  
Qin Xiao ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Botulinum Toxin ◽  
Gait Analysis ◽  
Rating Scale ◽  
Analog Scale ◽  
Toxin A ◽  
Timed Up And Go ◽  
Balance Test ◽  
Onabotulinum Toxin A

ABSTRACT: We investigated the effects of botulinum toxin on gait in Parkinson’s disease (PD) patients with foot dystonia. Six patients underwent onabotulinum toxin A injection and were assessed by Burke–Fahn–Marsden Dystonia Rating Scale (BFMDRS), visual analog scale (VAS) of pain, Timed Up and Go (TUG), Berg Balance Test (BBT), and 3D gait analysis at baseline, 1 month, and 3 months. BFMDRS (p = 0.002), VAS (p = 0.024), TUG (p = 0.028), and BBT (p = 0.034) were improved. Foot pressures at Toe 1 (p = 0.028) and Midfoot (p = 0.018) were reduced, indicating botulinum toxin’s effects in alleviating the dystonia severity and pain and improving foot pressures during walking in PD.

Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: Efficacy and possible mechanisms

2011 ◽  
Vol 69 (3) ◽  
pp. 151-157 ◽  
Author(s):  
Eigild Møller ◽  
Merete Karlsborg ◽  
Allan Bardow ◽  
Joan Lykkeaa ◽  
Flemming H. Nissen ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Amyotrophic Lateral Sclerosis ◽  
Botulinum Toxin ◽  
Lateral Sclerosis
Sign in / Sign up

Export Citation Format

Share Document